reSee.it Video Transcript AI Summary
Fenbendazole is an overlooked cancer drug with at least 12 proven anti-cancer mechanisms. It disrupts microtubule polymerization, induces cell cycle arrest, blocks glucose transport, increases tumor suppressor levels, inhibits cancer cell viability, migration, and invasion, induces apoptosis, autophagy, and necrosis, and inhibits angiogenesis and drug resistance. Mebendazole, a similar drug, is already approved by the FDA and in clinical trials for brain and colon cancers. However, there are no Fenbendazole clinical trials for cancer, likely because it is cheap, safe, and effective. Big pharma may not see a profit margin in it, which raises concerns about their motives. This highlights the issue of a society designed to make people sick, with pharmaceutical companies profiting from remedies.